Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cutland

Showing results (151-160 of 173) with videos related to

Pageof 18
Sort By:
Vaccine|August 6, 2016
Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety dataStefania Vergnano, Jim Buttery, Ben Cailes, et al.
Nature Immunology|June 15, 2023
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19Paulina Kaplonek, Deniz Cizmeci, Gaurav Kwatra, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 13, 2025
Sero-epidemiology of measles immunoglobulin G antibodies among newborns from South-East Asia and sub-Saharan Africa: an observational, multicenter studyCarine Bokop, Nisha Dhar, Alane Izu, et al.
The Lancet. Microbe|August 23, 2024
Prevalence of group B Streptococcus colonisation in mother-newborn dyads in low-income and middle-income south Asian and African countries: a prospective, observational studyGaurav Kwatra, Alane Izu, Clare Cutland, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 18, 2025
Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South AsiaCarine Bokop, Nisha Dhar, Alane Izu, et al.
Vaccine|May 6, 2023
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)Anthonet L Koen, Alane Izu, Vicky Baillie, et al.
Science Advances|September 14, 2019
The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremiaJohn Muthii Muriuki, Alexander J Mentzer, Gavin Band, et al.
The Lancet. HIV|August 20, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trialShabir A Madhi, Anthonet L Koen, Alane Izu, et al.
The Lancet. Infectious Diseases|October 23, 2022
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trialShabir A Madhi, Gaurav Kwatra, Simone I Richardson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
<i>OSBPL11</i> is an African-specific locus associated with 25-hydroxyvitamin D concentrations and cardiometabolic healthReagan M Mogire, John Muthii Muriuki, Ruth Fiona Bayimenye, et al.
Pageof 18

Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
Vaccine|August 6, 2016
Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety dataStefania Vergnano, Jim Buttery, Ben Cailes, et al.
Nature Immunology|June 15, 2023
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19Paulina Kaplonek, Deniz Cizmeci, Gaurav Kwatra, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 13, 2025
Sero-epidemiology of measles immunoglobulin G antibodies among newborns from South-East Asia and sub-Saharan Africa: an observational, multicenter studyCarine Bokop, Nisha Dhar, Alane Izu, et al.
The Lancet. Microbe|August 23, 2024
Prevalence of group B Streptococcus colonisation in mother-newborn dyads in low-income and middle-income south Asian and African countries: a prospective, observational studyGaurav Kwatra, Alane Izu, Clare Cutland, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 18, 2025
Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South AsiaCarine Bokop, Nisha Dhar, Alane Izu, et al.
Vaccine|May 6, 2023
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)Anthonet L Koen, Alane Izu, Vicky Baillie, et al.
Science Advances|September 14, 2019
The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremiaJohn Muthii Muriuki, Alexander J Mentzer, Gavin Band, et al.
The Lancet. HIV|August 20, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trialShabir A Madhi, Anthonet L Koen, Alane Izu, et al.
The Lancet. Infectious Diseases|October 23, 2022
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trialShabir A Madhi, Gaurav Kwatra, Simone I Richardson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
<i>OSBPL11</i> is an African-specific locus associated with 25-hydroxyvitamin D concentrations and cardiometabolic healthReagan M Mogire, John Muthii Muriuki, Ruth Fiona Bayimenye, et al.
Pageof 18